Azzad Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Azzad Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,242	Closed	-$689K	–	356
2022 Q3	$689K	Hold	6,242	–	–	0.07%	316
2022 Q2	$689K	Buy	+6,242	New	+$961K	0.07%	317
2020 Q3	–	Sell	-6,242	Closed	-$689K	–	304
2020 Q2	$689K	Sell	6,242 -1	-0%	-$111	0.16%	201
2020 Q1	$623K	Sell	6,243 -6,242	-50%	-$807K	0.18%	189
2019 Q4	$1.62M	Hold	12,485	–	–	0.19%	173
2019 Q3	$1.49M	Buy	12,485 +6,244	+100%	+$837K	0.18%	183
2019 Q2	$890K	Buy	6,241 +1,352	+28%	+$182K	0.24%	162
2019 Q1	$699K	Hold	4,889	–	–	0.2%	181
2018 Q4	$606K	Buy	4,889 +910	+23%	+$135K	0.2%	185
2018 Q3	$669K	Buy	+3,979	New	+$684K	0.18%	200

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Azzad Asset Management's JAZZ Position: Q4 2022 in Review

Azzad Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2022, closing a stake of 6,242 shares — an estimated $689K sold.

Azzad Asset Management first reported a position in JAZZ in Q3 2018 and held it in 10 quarters. The position peaked at $1.62M in Q4 2019. 485 funds tracked by Wall St. Rank hold JAZZ as of Q4 2022.

Azzad Asset Management reported no remaining Jazz Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Azzad Asset Management sold 6,242 Jazz Pharmaceuticals shares in Q4 2022, an estimated $689K.
Azzad Asset Management first reported a position in Jazz Pharmaceuticals in Q3 2018 and held it in 10 quarters.
Azzad Asset Management's Jazz Pharmaceuticals position peaked at $1.62M in Q4 2019.
485 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2022.

Based on Azzad Asset Management's 13F filing for Q4 2022, filed 1 Apr 2024.